It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
miRNAs modulate cardiomyocyte specification by targeting mRNAs of cell cycle regulators and acting in cardiac muscle lineage gene regulatory loops. It is unknown if or to-what-extent these miRNA/mRNA networks are operative during cardiomyocyte differentiation of adult cardiac stem/progenitor cells (CSCs). Clonally-derived mouse CSCs differentiated into contracting cardiomyocytes in vitro (iCMs). Comparison of “CSCs vs. iCMs” mRNome and microRNome showed a balanced up-regulation of CM-related mRNAs together with a down-regulation of cell cycle and DNA replication mRNAs. The down-regulation of cell cycle genes and the up-regulation of the mature myofilament genes in iCMs reached intermediate levels between those of fetal and neonatal cardiomyocytes. Cardiomyo-miRs were up-regulated in iCMs. The specific networks of miRNA/mRNAs operative in iCMs closely resembled those of adult CMs (aCMs). miR-1 and miR-499 enhanced myogenic commitment toward terminal differentiation of iCMs. In conclusions, CSC specification/differentiation into contracting iCMs follows known cardiomyo-MiR-dependent developmental cardiomyocyte differentiation trajectories and iCMs transcriptome/miRNome resembles that of CMs.
Scalise et al. examine the mRNAome and miRNAome of cardiomyocytes differentiated from murine adult cardiac stem cells (CSCs). Their results show that the differentiation process follows a trajectory of miRNA/mRNA expression that resembles that of adult cardiomyocytes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Magna Graecia University, Department of Experimental and Clinical Medicine, Catanzaro, Italy (GRID:grid.411489.1) (ISNI:0000 0001 2168 2547)
2 Magna Graecia University, Department of Medical and Surgical Sciences, Catanzaro, Italy (GRID:grid.411489.1) (ISNI:0000 0001 2168 2547)
3 University of Campania “L. Vanvitelli”, Department of Experimental Medicine, Naples, Italy (GRID:grid.411489.1)
4 University of Campania “Luigi Vanvitelli”, Department of Precision Medicine, Naples, Italy (GRID:grid.9841.4) (ISNI:0000 0001 2200 8888)
5 University of Salerno, Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, Salerno, Italy (GRID:grid.11780.3f) (ISNI:0000 0004 1937 0335); Clinical Research and Innovation, Clinica Montevergine, Mercogliano, Italy (GRID:grid.11780.3f)
6 University of Salerno, Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, Salerno, Italy (GRID:grid.11780.3f) (ISNI:0000 0004 1937 0335)
7 New York Medical College, Department of Physiology, Valhalla, USA (GRID:grid.260917.b) (ISNI:0000 0001 0728 151X)
8 Magna Graecia University, Department of Medical and Surgical Sciences, Catanzaro, Italy (GRID:grid.411489.1) (ISNI:0000 0001 2168 2547); New York Medical College, Department of Physiology, Valhalla, USA (GRID:grid.260917.b) (ISNI:0000 0001 0728 151X)